Cargando…

Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival

BACKGROUND: Sex determining region Y (SRY)-related high mobility groupbox 9 (SOX9) is an important transcription factor required for development, which regulates the expression of target genes in the associated pathway. The aim of this study was to describe the expression of SOX9 in human non-small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chun-Hui, Ye, Li-Ping, Ye, Shi-Xing, Li, Yan, Zhang, Xin-Yin, Xu, Xin-Yu, Gong, Li-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313873/ https://www.ncbi.nlm.nih.gov/pubmed/22385677 http://dx.doi.org/10.1186/1756-9966-31-18

Ejemplares similares

SOX9 drives the epithelial–mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway
por: Huang, Jing-Qiang, et al.
Publicado: (2019)

Expression and significance of SOX2 in non-small cell lung carcinoma
por: Ying, Jie, et al.
Publicado: (2016)

Unique profile on the progress free survival and overall survival in patients with advanced non-small cell lung cancer in the Qujing area, Southwest China
por: Ma, Yuhui, et al.
Publicado: (2023)

Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer
por: Xinli, Wang, et al.
Publicado: (2022)

Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor
por: Yuan, Xiaodong, et al.
Publicado: (2021)

Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival
por: Liao, Wen-Ting, et al.
Publicado: (2011)

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2019)

Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer
por: Li, Xinxin, et al.
Publicado: (2012)

Copy‐number variation of MCL1 predicts overall survival of non‐small‐cell lung cancer in a Southern Chinese population
por: Yin, Jieyun, et al.
Publicado: (2016)

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
por: Imai, Hisao, et al.
Publicado: (2016)

Identification of HMG-box family establishes the significance of SOX6 in the malignant progression of glioblastoma
por: Jiang, Lan, et al.
Publicado: (2020)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
por: Masubuchi, Ken, et al.
Publicado: (2022)

Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
por: Li, Qingbao, et al.
Publicado: (2016)

Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Yang, Yin, et al.
Publicado: (2022)

Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
por: Feng, Yu-Min, et al.
Publicado: (2015)

Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer
por: Miao, Ti-wei, et al.
Publicado: (2022)

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
por: Ton, Thanh G.N., et al.
Publicado: (2022)

Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer
por: Shi, Liang, et al.
Publicado: (2018)

Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
por: Yoon, Hong In, et al.
Publicado: (2016)

Clinical impact of post‐progression survival on overall survival in elderly patients with extensive disease small‐cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2016)

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis
por: Yang, Yin, et al.
Publicado: (2022)

Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients
por: Zhai, Ting, et al.
Publicado: (2022)

Prognostic and diagnostic value of SOX9 in cirrhotic and noncirrhotic hepatocellular carcinoma
por: Xu, Zhong-Ping, et al.
Publicado: (2021)

Overexpression of SOX9 alleviates the progression of human osteoarthritis in vitro and in vivo
por: Ouyang, Yuanming, et al.
Publicado: (2019)

Intraoperative hypotension is associated with shortened overall survival after lung cancer surgery
por: Huang, Wen-Wen, et al.
Publicado: (2020)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

SOX9 inactivation affects the proliferation and differentiation of human lung organoids
por: Li, Lian, et al.
Publicado: (2021)

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)

NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2018)

Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival
por: Mendieta-Carmona, Victoriano, et al.
Publicado: (2023)

miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9
por: Li, Zhihong, et al.
Publicado: (2022)

High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma
por: Han, Fei, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of SOX9 expression in gastric cancer patients: A meta-analysis
por: Wang, Qian, et al.
Publicado: (2022)

The Predictive Significance of Prognostic Nutritional Index and Serum Albumin/Globulin Ratio on the Overall Survival of Penile Cancer Patients Undergoing Penectomy
por: Song, Wei-Jie, et al.
Publicado: (2022)

Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma
por: Capaccione, Kathleen M., et al.
Publicado: (2014)

SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
por: Yuan, Xiaodong, et al.
Publicado: (2018)

Prediagnosis Smoking Cessation and Overall Survival Among Patients With Non–Small Cell Lung Cancer
por: Wang, Xinan, et al.
Publicado: (2023)

Upfront brain radiotherapy improves intracranial progression-free survival but not overall survival in lung adenocarcinoma patients with brain metastases: a retrospective, single-institutional analysis from China
por: Jiang, Aijun, et al.
Publicado: (2022)

Significance of different response evaluation criteria in predicting progression‐free survival of lung cancer with certain imaging characteristics
por: Yang, Dengxia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9ih1updih3a6r44sglcv61j21k